Endocrine disruptors have become a major issue in environmental health discussions. Found in certain plastics, pesticides, cosmetics, textiles, and food packaging, these chemical substances can interfere with the body’s hormonal system and potentially affect human health.
Over the past two decades, scientific publications on the subject have increased significantly. Yet regulation continues to move slowly, and consumers often remain poorly informed about their daily exposure.
So why is there still such a gap between scientific knowledge and regulatory action?
Chemicals That Can Act at Very Low Doses
The endocrine system controls essential bodily functions such as growth, reproduction, metabolism, sleep, and brain development. Endocrine disruptors can interfere with these processes by mimicking hormones or altering the way they function.
What makes these substances particularly difficult to assess is that their effects may occur at extremely low doses, especially during sensitive periods such as pregnancy or early childhood.
This is precisely why researchers and public health agencies have devoted increasing attention to these chemicals in recent years.
A Regulatory System Built on Sometimes Outdated Testing Methods
Chemical regulation has historically relied on standardized toxicological testing protocols. These tests are designed to evaluate the safety of substances before they reach the market.
However, several researchers have pointed out that traditional regulatory tests do not always capture subtle endocrine-related effects or newly identified biological mechanisms. In their article published in Environmental Science: Processes & Impacts, Marlene Agerstrand and colleagues explain that standardized testing methods have sometimes been criticized for failing to address endpoints now considered highly sensitive and relevant in toxicology.
The authors also note that independent academic studies are still difficult to integrate into some regulatory assessments because they do not always match the technical reporting standards required by agencies.
Why Scientific Assessments Sometimes Reach Different Conclusions
One of the best-known examples concerns glyphosate. In 2015, the International Agency for Research on Cancer (IARC) classified it as “probably carcinogenic to humans,” while the European Food Safety Authority (EFSA) concluded that it was “unlikely” to pose a carcinogenic risk under normal exposure conditions.
In their paper, Agerstrand and colleagues explain that these differences can partly result from variations in the studies selected and the evaluation criteria used by different agencies.
This situation illustrates a broader challenge: science produces complex and sometimes conflicting data, while regulatory systems require harmonized criteria to make decisions.
A Lack of Transparency for Consumers
Even when substances are identified as potentially concerning, information often remains difficult for the public to access.
In many cases, consumers do not know:
- which substances are present in products;
- what risks are suspected;
- or what safer alternatives may exist.
For years, NGOs and public institutions have called for clearer labeling of hazardous substances, including endocrine disruptors.
More transparent labeling would not only improve consumer awareness, but could also encourage manufacturers to develop safer alternatives.
The Precautionary Principle at the Center of the Debate
The issue of endocrine disruptors ultimately raises a broader question about how societies manage health risks.
Should regulators wait for definitive proof before restricting a substance? Or should action be taken earlier when credible scientific concerns already exist?
In theory, the European Union applies the precautionary principle in environmental policy. In practice, however, regulatory procedures remain slow and complex because they must balance scientific evidence, economic considerations, and industrial interests.
A Regulatory System Still Evolving
In recent years, European regulations have started to evolve. Certain substances, such as bisphenol A, have been restricted in specific applications, and the European Union has progressively introduced criteria for identifying endocrine disruptors.
Still, many scientists argue that current assessment systems need further modernization in order to better account for recent knowledge regarding hormonal effects, low-dose exposure, and chronic exposure patterns.
The challenge goes far beyond chemistry alone. It concerns the ability of modern societies to translate scientific knowledge into public policies that are transparent, understandable, and genuinely protective of public health.
Sources
- Agerstrand M. et al. An academic researcher’s guide to increased impact on regulatory assessment of chemicals, Environmental Science: Processes & Impacts, 2017.
- World Health Organization (WHO) — State of the Science of Endocrine Disrupting Chemicals.
- European Environment Agency — reports on endocrine disruptors and the precautionary principle.